Myhre and LAPS syndromes: clinical and molecular review of 32 patients.

Eur J Hum Genet 2014 Nov 15;22(11):1272-7. Epub 2014 Jan 15.

INSERM U781 Unit, Department of Genetics, Institut Imagine, Paris Descartes University-Sorbonne Paris Cité, Necker Enfants-Malades Hospital, Paris, France.

Myhre syndrome is characterized by short stature, brachydactyly, facial features, pseudomuscular hypertrophy, joint limitation and hearing loss. We identified SMAD4 mutations as the cause of Myhre syndrome. SMAD4 mutations have also been identified in laryngotracheal stenosis, arthropathy, prognathism and short stature syndrome (LAPS). This study aimed to review the features of Myhre and LAPS patients to define the clinical spectrum of SMAD4 mutations. We included 17 females and 15 males ranging in age from 8 to 48 years. Thirty were diagnosed with Myhre syndrome and two with LAPS. SMAD4 coding sequence was analyzed by Sanger sequencing. Clinical and radiological features were collected from a questionnaire completed by the referring physicians. All patients displayed a typical facial gestalt, thickened skin, joint limitation and muscular pseudohypertrophy. Growth retardation was common (68.7%) and was variable in severity (from -5.5 to -2 SD), as was mild-to-moderate intellectual deficiency (87.5%) with additional behavioral problems in 56.2% of the patients. Significant health concerns like obesity, arterial hypertension, bronchopulmonary insufficiency, laryngotracheal stenosis, pericarditis and early death occurred in four. Twenty-nine patients had a de novo heterozygous SMAD4 mutation, including both patients with LAPS. In 27 cases mutation affected Ile500 and in two cases Arg496. The three patients without SMAD4 mutations had typical findings of Myhre syndrome. Myhre-LAPS syndrome is a clinically homogenous condition with life threatening complications in the course of the disease. Our identification of SMAD4 mutations in 29/32 cases confirms that SMAD4 is the major gene responsible for Myhre syndrome.

Download full-text PDF

Source
http://dx.doi.org/10.1038/ejhg.2013.288DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4200423PMC
November 2014
160 Reads
2 Citations
4.350 Impact Factor

Publication Analysis

Top Keywords

smad4 mutations
20
myhre syndrome
20
myhre laps
8
smad4
8
short stature
8
syndrome laps
8
laryngotracheal stenosis
8
joint limitation
8
patients
7
syndrome
7
myhre
7
mutations
5
deficiency 875%
4
875% additional
4
additional behavioral
4
intellectual deficiency
4
hypertension bronchopulmonary
4
severity -55
4
-55 mild-to-moderate
4
mild-to-moderate intellectual
4

References

(Supplied by CrossRef)

SA Myhre et al.
Clin Genet 1981

LE Becerra-Solano et al.
Clin Dysmorphol 2008

L Burglen et al.
J Med Genet 2003

NO Davalos et al.
Clin Dysmorphol 2003

D Garcia-Cruz et al.
Clin Genet 1993

MG Lopez-Cardona et al.
Clin Dysmorphol 2004

R McGowan et al.
Eur J Med Genet 2011

I Rulli et al.
Am J Med Genet A 2005

MA Soljak et al.
Clin Genet 1983

L Titomanlio et al.
Am J Med Genet 2001

MA van Steensel et al.
Am J Med Genet A 2005

Similar Publications